Brown Advisory’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,059
Closed -$818K 1411
2025
Q4
$818K Sell
8,059
-6,023
-43% -$484K ﹤0.01% 903
2025
Q3
$770K Buy
14,082
+3,006
+27% +$150K ﹤0.01% 907
2025
Q2
$589K Buy
11,076
+5,818
+111% +$296K ﹤0.01% 956
2025
Q1
$228K Sell
5,258
-40
-0.8% -$2.03K ﹤0.01% 1227
2024
Q4
$298K Sell
5,298
-1,142
-18% -$71.1K ﹤0.01% 1159
2024
Q3
$439K Sell
6,440
-1,016
-14% -$57.3K ﹤0.01% 1016
2024
Q2
$315K Sell
7,456
-692
-8% -$38.1K ﹤0.01% 1063
2024
Q1
$563K Sell
8,148
-139
-2% -$8.79K ﹤0.01% 909
2023
Q4
$613K Sell
8,287
-1,489
-15% -$97.6K ﹤0.01% 878
2023
Q3
$667K Sell
9,776
-322
-3% -$27.3K ﹤0.01% 837
2023
Q2
$948K Sell
10,098
-535
-5% -$41.7K ﹤0.01% 762
2023
Q1
$721K Sell
10,633
-160
-1% -$10.3K ﹤0.01% 833
2022
Q4
$534K Sell
10,793
-655
-6% -$26.8K ﹤0.01% 895
2022
Q3
$372K Sell
11,448
-1,313
-10% -$54.1K ﹤0.01% 925
2022
Q2
$502K Sell
12,761
-1,478
-10% -$79K ﹤0.01% 844
2022
Q1
$995K Sell
14,239
-2,554
-15% -$187K ﹤0.01% 714
2021
Q4
$1.31M Sell
16,793
-1,538
-8% -$136K ﹤0.01% 678
2021
Q3
$1.75M Sell
18,331
-16,138
-47% -$1.7M ﹤0.01% 594
2021
Q2
$4.29M Sell
34,469
-1,002
-3% -$120K 0.01% 481
2021
Q1
$4.67M Buy
+35,471
New +$4.86M 0.01% 475
2019
Q2
Sell
-16,446
Closed -$1.43M 1097
2019
Q1
$1.43M Sell
16,446
-6,309
-28% -$537K ﹤0.01% 722
2018
Q4
$1.44M Sell
22,755
-13,571
-37% -$931K ﹤0.01% 663
2018
Q3
$2.87M Buy
36,326
+3,787
+12% +$247K 0.01% 569
2018
Q2
$1.95M Buy
32,539
+25,505
+363% +$1.37M 0.01% 628
2018
Q1
$284K Buy
7,034
+690
+11% +$33.7K ﹤0.01% 995
2017
Q4
$334K Sell
6,344
-1,459
-19% -$77.9K ﹤0.01% 1003
2017
Q3
$368K Buy
+7,803
New +$314K ﹤0.01% 941

Other funds holding EXAS

Brown Advisory's EXAS Position: Q1 2026 in Review

Brown Advisory sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 8,059 shares — an estimated $818K sold.

Brown Advisory first reported a position in EXAS in Q3 2017 and held it in 27 quarters. The position peaked at $4.67M in Q1 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Brown Advisory reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Brown Advisory sold 8,059 Exact Sciences shares in Q1 2026, an estimated $818K.
  • Brown Advisory first reported a position in Exact Sciences in Q3 2017 and held it in 27 quarters.
  • Brown Advisory's Exact Sciences position peaked at $4.67M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.